Rheumatology Best Practice Awards 2013 - results

Our best practice awards case studies offer service models and pathways which will help providers and commissioners to appreciate what 'excellent' looks like. They will be able to use them to examine service configurations at their local level, so if they decide to reconfigure any changes will be based on solid evidence.

Finalists were shortlisted after nominations by British Society for Rheumatology regional chairs, service reports and visits from a specialist panel. A judging panel of experts, which included representatives from BSR, the European League Against Rheumatism and NICE, then met on 30 September to assess the finalists.

Each case study shows how innovative work has improved patient experience, health care value, and outcomes. They offer examples of ways in which rheumatology services can be improved across the NHS.

The results of the expert panel evaluation are below in alphabetical order by category:

Best practice outstanding


Best practice



Highly commended


  • Derby Hospital 
  • NASS 
  • Northwick Park Hospital
Our finalists were shortlisted following nominations by BSR regional chairs, service reports and visits from a specialist panel. They were:

-- Henry Penn, Northwick Park Hospital
-- Bruce Kirkham, Guys & St Thomas'
-- Christina Estrach, Aintree Hospital
-- Chris Holroyd, Southampton General
-- Robert Marshall, Bristol Royal
-- Andrew Astor, Addenbrookes Hospital
-- Richard Hull, Portsmouth Hospital NHS Trust
-- Susie Earl, Richard Haigh and Ravik Mascarenhas, Royal Devon and Exeter NHS Foundation Trust
-- Vinodh Devakumar, Pennine Musculoskeletal Partnership Ltd
-- Marion Regan, Derby Hospital
-- Sonya Abraham, Imperial College London Healthcare NHS Trust
-- Alun Cooper and Mary Elliott, Sussex Community NHS Trust
-- Frank McKenna, Trafford General Hospital
-- Rachel Gorodkin, Manchester Royal Infirmary
-- Debbie Cook, NASS
-- Ailsa Bosworth, NRAS

Sponsorship statement

This best practice case study project has been sponsored by UCB and supported by a medical education grant from Pfizer. UCB and Pfizer have not had any influence over content. The editorial control remained with the British Society of Rheumatology.


UCB logo 
 
Pfizer 
We gratefully acknowledge the generous support of our sponsors, which enabled the case study project to take place.